Recent advances in management of bronchiolitis

Indian Pediatrics

Volumn 50, Issue 10, 2013, Pages 939-949

  Verma, Nishant ^a   Lodha, Rakesh ^a   Kabra, S K ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Bronchiolitis; CPAP; Epinephrine; Hypertonic saline; Surfactant

Indexed keywords

ADRENALIN; ALPHA2A INTERFERON; ANTIBIOTIC AGENT; ANTIVIRUS AGENT; BRONCHODILATING AGENT; CLARITHROMYCIN; CORTICOSTEROID; DEXAMETHASONE; FUROSEMIDE; HELIOX; LACTATE DEHYDROGENASE; LEFLUNOMIDE; MACROLIDE; MONOCLONAL ANTIBODY; MONTELUKAST; MOTAVIZUMAB; PALIVIZUMAB; RIBAVIRIN; SALBUTAMOL; SODIUM CHLORIDE; SURFACTANT;

ADENOVIRUS; ARTICLE; ARTIFICIAL VENTILATION; ASSISTED VENTILATION; BACTERIAL INFECTION; BACTERIAL PNEUMONIA; BREATHING EXERCISE; BRONCHIOLITIS; BRONCHOSPASM; CLINICAL ASSESSMENT; CLINICAL FEATURE; CORONAVIRUS; DISEASE COURSE; DISEASE SEVERITY; HEALTH CARE PERSONNEL; HOSPITAL ADMISSION; HUMAN; HYDRATION; IMMUNOPROPHYLAXIS; INFANT; INFLUENZA VIRUS; LABORATORY TEST; MAJOR CLINICAL STUDY; OXYGENATION; PARAINFLUENZA VIRUS; POSITIVE END EXPIRATORY PRESSURE; PRACTICE GUIDELINE; PULSE OXIMETRY; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; RHINOVIRUS; RISK FACTOR; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT;

BRONCHIOLITIS; HUMANS; INFANT; INFANT, NEWBORN;

EID: 84887206236     PISSN: 00196061     EISSN: 09747559     Source Type: Journal    
DOI: 10.1007/s13312-013-0265-z     Document Type: Article

References (74)

1. American Academy of Pediatrics Subcommittee on Diagnosis and Management of Bronchiolitis. Diagnosis and management of bronchiolitis. Pediatrics. 2006;118:1774-1793. (Pubitemid 46393839)
2. Hanson IC, Shearer WT. Bronchiolitis. In: McMillan JA, Feigin RD, DeAngelis C, Jones MD, eds. Oski's Pediatrics: Principles and Practice, 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2006. p.1391.
3. Wright AL, Taussig LM, Ray CG, Harrison HR, Holberg CJ. The Tucson Children's Respiratory Study II. Lower respiratory tract illness in the first year of life. Am J Epidemiol. 1989;129:1232-1264.
4. Gupta S, Shamsundar R, Shet A, Chawan R, Srinivasa H. Prevalence of respiratory syncytial virus infection among hospitalized children presenting with acute lower respiratory tract infections. Indian J Pediatr. 2011;78:1495-147.
5. Bharaj P, Sullender WM, Kabra SK, Mani K, Cherian J, Tyagi V, et al. Respiratory viral infections detected by multiplex PCR among pediatric patients with lower respiratory tract infections seen at an urban hospital in Delhi from 2005 to 2007. Virol J. 2009;26:89
6. Maitreyi RS, Broor S, Kabra SK, Ghosh M, Seth P, Dar L, et al. Rapid detection of respiratory viruses by centrifugation enhanced cultures from children with acute lower respiratory tract infections. J Clin Virol. 2000;16:41-47. (Pubitemid 30066480)
7. Banerjee S, Bharaj P, Sullender W, Kabra SK, Broor S. Human metapneumovirus infections among children with acute respiratory infections seen in a large referral hospital in India. J Clin Virol. 2007;38:70-72. (Pubitemid 44881416)
8. Bharaj P, Sullender WM, Kabra SK, Broor S. Human bocavirus infection in children with acute respiratory tract infection in India. J Med Virol. 2010;82:812-816.
9. Stempel HE, Martin ET, Kuypers J, Englund JA, Zerr DM. Multiple viral respiratory pathogens in children with bronchiolitis. Acta Paediatr. 2009; 98:123-126.
10. Zorc JJ, Hall CB. Bronchiolitis: Recent evidence on diagnosis and management. Pediatrics. 2010;125:342-349.
11. Canducci F, Debiaggi M, Sampaolo M, Marinozzi MC, Berrè S, Terulla C, et al. Two-year prospective study of single infections and co-infections by respiratory syncytial virus and viruses identified recently in infants with acute respiratory disease. J Med Virol. 2008;80:716-723. (Pubitemid 351358572)
12. Milder E, Arnold JC. Human metapneumovirus and human bocavirus in children. Pediatr Res. 2009;65:78R-83R.
13. Williams JV, Harris PA, Tollefson SJ, Halburnt-Rush LL, Pingsterhaus JM, Ed-wards KM, et al. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med. 2004;350:443-450. (Pubitemid 38133764)
14. Cherian T, Simoes EA, Steinhoff MC, Chitra K, John M, Raghupathy P, et al. Bronchiolitis in tropical South India. Am J Dis Child. 1990;144:1026-1030. (Pubitemid 20326413)
15. Kneyber MC, Brandenburg AH, de Groot R, Joosten KF, Rothbarth PH, Ott A, et al. Risk factors for respiratory syncytial virus associated apnoea. Eur J Pediatr. 1998;157:331-335. (Pubitemid 28178138)
16. Swingler GH, Hussey GD, Zwarenstein M. Duration of illness in ambulatory children diagnosed with bronchiolitis. Arch Pediatr Adolesc Med. 2000;154:997-1000.
17. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA. 1999;282: 1440-1446. (Pubitemid 29493797)
18. Shaw KN, Bell LM, Sherman NH. Outpatient assessment of infants with bronchiolitis. Am J Dis Child. 1991;145:151-155.
19. Wang EE, Law BJ, Stephens D. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr. 1995;126:212-219.
20. Meissner HC. Selected populations at increased risk from respiratory syncytial virus infection. Pediatr Infect Dis J. 2003;22:S40-S44.
21. McConnochie KM, Roghmann KJ. Parental smoking, presence of older siblings, and family history of asthma increase risk of bronchiolitis. Am J Dis Child. 1986;140:806-812. (Pubitemid 16033992)
22. Voets S, van Berlaer G, Hachimi-Idrissi S. Clinical predictors of the severity of bronchiolitis. Eur J Emerg Med. 2006;13:134-138. (Pubitemid 44153099)
23. Mansbach JM, Clark S, Christopher NC, LoVecchio F, Kunz S, Acholonu U, et al. Prospective multicenter study of bronchiolitis: predicting safe discharges from the emergency department. Pediatrics. 2008;121:680-688.
24. Thorburn K. Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection. Arch Dis Child. 2009; 94:99-103.
25. Schuh S, Lalani A, Allen U, Manson D, Babyn P, Stephens D, et al. Evaluation of the utility of radiography in acute bronchiolitis. J Pediatr. 2007;150:429-433. (Pubitemid 46437329)
26. Purcell K, Fergie J. Lack of usefulness of an abnormal white blood cell count for predicting a concurrent serious bacterial infection in infants and young children hospitalized with respiratory syncytial virus lower respiratory tract infection. Pediatr Infect Dis J. 2007; 26:311-315. (Pubitemid 46596654)
27. Laham FR, Trott AA, Bennett BL, Kozinetz CA, Jewell AM, Garofalo RP, et al. LDH concentration in nasal-wash fluid as a biochemical predictor of bronchiolitis severity. Pediatrics. 2010;125:e225-233.
28. Ong GM, Wyatt DE, O'Neill HJ, McCaughey C, Coyle PV. A comparison of nested polymerase chain reaction and immunofluorescence for the diagnosis of respiratory in children with bronchiolitis. J Hosp Infect. 2001;49:122-128. (Pubitemid 32982686)
29. Hguenin A, Moutte L, Renois F, Leveque N, Talmud D, Abely M, et al. Broad respiratory virus detection in infants hospitalized for bronchiolitis by use of a multiplex RT-PCR DNA microarray system. J Med Virol. 2012;84: 79-85.
30. Reis AD, Fink MCD, Machado CM, Paz Jr(I) JP, Oliveira RR, Tateno AF, et al. Comparison of direct immunofluorescence, conventional cell culture and polymerase chain reaction techniques for detecting respiratory syncytial virus in nasopharyngeal aspirates from infants. Rev Inst Med Trop S Paulo. 2008;50:37-40. (Pubitemid 351416353)
31. Smyth RL, Openshaw PJ. Bronchiolitis. Lancet. 2006;368:312-322. (Pubitemid 44067248)
32. van Steensel-Moll HA, Hazelzet JA, van der Voort E, Neijens HJ, Hackeng WH. Excessive secretion of antidiuretic hormone in infections with respiratory syncytial virus. Arch Dis Child. 1990;65:1237-1239. (Pubitemid 20356893)
33. Steiner RWP. Treating acute bronchiolitis associated with RSV. Am Family Physician. 2004;69:325-330.
34. Schroeder AR, Marmor AK, Pantell RH, Newman TB. Impact of pulse oximetry and oxygen therapy on length of stay in bronchiolitis hospitalizations. Arch Pediatr Adolesc Med. 2004;158:527-530. (Pubitemid 38720482)
35. Unger S, Cunningham S. Effect of oxygen supplementation on length of stay for infants hospitalized with acute viral bronchiolitis. Pediatrics. 2008;121:470-475.
36. Donlan M, Fontela PS, Puligandla PS. Use of continuous positive airway pressure (CPAP) in acute viral bronchiolitis: A systematic review. Pediatr Pulmonol. 2011;46:736-746.
37. Smith TC, Marini JJ. Impact of PEEP on lung mechanics and work of breathing in severe airflow obstruction. J Appl Physiol. 1988;65:1488-1499.
38. 2O continuous positive airway pressure versus conventional oxygen therapy in severe viral bronchiolitis: A randomized trial. Pediatr Pulmonol. 2013;48:45-51.
39. Essouri S, Durand P, Chevret L, Balu L, Devictor D, Fauroux B, et al. Optimal level of nasal continuous positive airway pressure in severe viral bronchiolitis. Intensive Care Med. 2011;37:2002-2007.
40. Wohl MEB. Bronchiolitis. In: Chernick V, Boat TF, Wilmott RW, Bush A, editors. Kendig's Disorders of the Respiratory Tract in Children. 6th ed. Philadelphia: Saunders Elsevier Publishers; 1998. P. 423-432.
41. Roqué i Figuls M, Giné-Garriga M, Granados Rugeles C, Perrotta C. Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old. Cochrane Database Syst Rev. 2012;2:CD004873.
42. Gadomski AM, Brower M. Bronchodilators for bronchiolitis. Cochrane Database Syst Rev. 2010;12:CD001266.
43. Hartling L, Bialy LM, Vandermeer B, Tjosvold L, Johnson DW, Plint AC, et al. Epinephrine for bronchiolitis. Cochrane Database Syst Rev. 2011;6:CD003123.
44. Patel H, Gouin S, Platt RW. Randomized, double-blind, placebo-controlled trial of oral albuterol in infants with mild-to-moderate acute viral bronchiolitis. J Pediatr. 2003;142:509-514. (Pubitemid 36623560)
45. Fernandes RM, Bialy LM, Vandermeer B, Tjosvold L, Plint AC, Patel H, et al. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev. 2010;10:CD004878.
46. Davison C, Ventre KM, Luchetti M, Randolph AG. Efficacy of interventions for bronchiolitis in critically ill infants: A systematic review and meta-analysis. Pediatr Crit Care Med. 2004;5:482-489.
47. Plint AC, Johnson DW, Patel H, Wiebe N, Correll R, Brant R, et al. Epinephrine and dexamethasone in children with bronchiolitis. N Engl J Med. 2009;360:2079-2089.
48. Blom DJM, Ermers M, Bont L, van Woensel JBM, van Aalderen WMC. Inhaled corticosteroids during acute bronchiolitis in the prevention of post-bronchiolitic wheezing. Cochrane Database Syst Rev. 2007;1:CD004881.
49. Ermers MJJ, Rovers MM, van Woensel JB, Kimpen JLL, Bont LJ, on behalf of the RSV Corticosteroid Study Group. The effect of high dose inhaled corticosteroids on wheeze in infants after respiratory syncytial virus infection: randomised double blind placebo controlled trial. BMJ. 2009;338:b897.
50. Davies HD, Matlow A, Petric M, Glazier R, Wang EE. Prospective comparative study of viral, bacterial and atypical organisms identified in pneumonia and bronchiolitis in hospitalized Canadian infants. Pediatr Infect Dis J. 1996;15:371-375. (Pubitemid 26119281)
51. Spurling GK, Doust J, Del Mar CB, Eriksson L. Antibiotics for bronchiolitis in children. Cochrane Database Syst Rev. 2011;6:CD005189.
52. Tahan F, Ozcan A, Koc N. Clarithromycin in the treatment of RSV bronchiolitis: a double-blind, randomised, placebo-controlled trial. Eur Respir J. 2007;29:91-97. (Pubitemid 46092003)
53. Zhang L, Mendoza-Sassi RA, Wainwright C, Klassen TP. Nebulized hypertonic saline solution for acute bronchiolitis in infants. Cochrane Database Syst Rev. 2008;4:CD006458.
54. Luo Z, Liu E, Luo J, Li S, Zeng F, Yang X, et al. Nebulized hypertonic saline/salbutamol solution treatment in hospitalized children with mild to moderate bronchiolitis. Pediatr Int. 2010;52:199-202.
55. Anil AB, Anil M, Saglam AB, Cetin N, Bal A, Aksu N. High volume normal saline alone is as effective as nebulized salbutamol-normal saline, epinephrine-normal saline, and 3% saline in mild bronchiolitis. Pediatr Pulmonol. 2010;45:41-47.
56. Bar A, Srugo I, Amirav I, Tzverling C, Naftali G, Kugelman A. Inhaled furosemide in hospitalized infants with viral bronchiolitis: A randomized, double-blind, placebo-controlled pilot study. Pediatr Pulmonol. 2008;43:261-267. (Pubitemid 351374458)
57. Umoren R, Odey F, Meremikwu MM. Steam inhalation or humidified oxygen for acute bronchiolitis in children up to three years of age. Cochrane Database Syst Rev. 2011;1: CD006435.
58. Can D, Inan G, Yendur G, Oral R, Gunay I. Salbutamol or mist in acute bronchiolitis. Acta Paediatrica Japonica. 1998;40:252-255. (Pubitemid 28292616)
59. Amirav I, Luder AS, Kruger N, Borovitch Y, Babai I, Miron D, et al. A double-blind, placebo-controlled, randomized trial of montelukast for acute bronchiolitis. Pediatrics. 2008; 122:e1249-e1255.
60. Zedan M, Gamil N, El-Assmy M, Fayez E, Nasef N, Fouda A, et al. Montelukast as an episodic modifier for acute viral bronchiolitis: a randomized trial. Allergy Asthma Proc. 2010;31:147-153.
61. Kim CK, Choi J, Kim HB, Callaway Z, Shin BM, Kim JT, et al. A randomized intervention of montelukast for postbronchiolitis: effect on eosinophil degranulation. J Pediatr. 2010;156:749-754.
62. Bisgaard H, Flores-Nunez A, Goh A, Azimi P, Halkas A, Malice MP, et al. Study of montelukast for the treatment of respiratory symptoms of post-respiratory syncytial virus bronchiolitis in children. Am J Respir Crit Care Med. 2008;178:854-860.
63. Liet JM, Ducruet T, Gupta V, Cambonie G. Heliox inhalation therapy for bronchiolitis in infants. Cochrane Database Syst Rev. 2010;4:CD006915.
64. Eber E. Treatment of acute viral bronchiolitis. Open Microbiol J. 2011;5:159-164.
65. King VJ, Viswanathan M, Bordley WC, Jackman AM, Sutton SF, Lohr KN, et al. Pharmacologic treatment of bronchiolitis in infants and children. Arch Pediatr Adolesc Med. 2004;158:127-137. (Pubitemid 38173966)
66. Dunn MC, Knight DA, Waldman WJ. Inhibition of respiratory syncytial virus in vitro and in vivo by the immunosuppressive agent leflunomide. Antivir Ther. 2011;16:309-317.
67. Olszewska W, Ispas G, Schnoeller C, Sawant D, Van de Casteele T, Nauwelaers D, et al. Antiviral and lung protective activity of a novel respiratory syncytial virus fusion inhibitor in a mouse model. Eur Respir J. 2011;38:401-408.
68. Douglas JL, Panis ML, Ho E, Lin KY, Krawczyk SH, Grant DM, et al. Small Molecules VP-14637 and JNJ-2408068 Inhibit Respiratory Syncytial Virus Fusion by Similar Mechanisms. Antimicrobial Agents Chemoth. 2005;49:2460-2466. (Pubitemid 40734480)
69. Deffrasnes C, Hamelin M, Prince GA, Boivin G. Identification and Evaluation of a Highly Effective Fusion Inhibitor for Human Metapneumovirus. Antimicrobial Agents Chemoth. 2008;52:279-287.
70. Jat KR, Chawla D. Surfactant therapy for bronchiolitis in critically ill infants. Cochrane Database Syst Rev. 2012;9:CD009194.
71. Mejías A, Ramilo O. Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in highrisk infants. Biologics. 2008;2:433-439.
72. Fuller HL, Del Mar CB. Immunoglobulin treatment for respiratory syncytial virus infection. Cochrane Database Syst Rev. 2006;4:CD004883.
73. American Academy of Pediatrics. Red Book: 2006 Report of the Committee on Infectious Diseases. 27th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2006.
74. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn. 2003. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. Pediatrics. 2003;112:1442-1446. (Pubitemid 37523437)